Aisling Capital related stories
All articles and analysis
Don’t Shed a Tear for Eye InvestorsVenture capitalists have put a lot of money over the past couple of years into companies developing treatments for eye disease. Now they’re seeing some ROI. This week, venture backers in LensX Lasers got what looks on paper to be a very nice exit that could turn into a much better one, when Alcon announced that it has entered into a definitive agreement to acquire the company. Alcon will pay US $361.5 million in cash for LenSX, a developer of a laser used in cataract treatment, plus maximum contingent payments of US $382.5 million if it hits agreed-upon milestones. Four-year-old LenSx, which developed what Alcon says developed is first femtosecond laser to receive U.S. Food and Drug Administration clearance for use as a part of cataract surgery, previously raised $32 million in venture funding. The Aliso Viejo, Calif.-based company’s investors include InterWest Partners, SV Life Sciences Advisers and Versant Ventures.
- Week in deals, June 14, 2010
Summary of tech companies and other startups in North America that raised venture financing in the past week
- Sirion Sells Zirgan Rights to Bausch & Lomb
Sirion Therapeutics Inc. has sold the assets and U.S. rights for Zirgan, a topical anti-viral for the treatment of corneal ulcers, to Bausch + Lomb. No financial terms were disclosed. Sirion is a Tampa, Fla.-based drug company focused on ophthalmic products. It has raised over $45 million in VC funding from Aisling Capital, Investor Growth Capital, Atlas Venture, Advent International, Bear Sterns Healthcare Value Partners and NovaQuest.
- Sirion Sells Zirgan Rights to Bausch & Lomb
Sirion Therapeutics Inc. has sold the assets and U.S. rights for Zirgan, a topical anti-viral for the treatment of corneal ulcers, to Bausch + Lomb. No financial terms were disclosed. Sirion is a Tampa, Fla.-based drug company focused on ophthalmic products. It has raised over $45 million in VC funding from Aisling Capital, Investor Growth Capital, Atlas Venture, Advent International, Bear Sterns Healthcare Value Partners and NovaQuest.
- peHUB Wire: Tuesday, June 8, 2010
Random Ramblings
- peHUB Wire: Tuesday, June 8, 2010
Random Ramblings
- Exit watch, week of June 7, 2010
News briefs about Invite Media and other VC-backed companies getting acquired in the past week
- peHUB Wire: Thursday, June 3, 2010
Random Ramblings
- peHUB Wire: Thursday, June 3, 2010
Random Ramblings
- Zeltiq Raises $25 Million
Zeltiq, a Pleasanton, Calif.-based developer of non-invasive fat-reduction technology, has raised $25 million in Series D funding. Aisling Capital led the round, and was joined by return backers Venrock, Frazier Healthcare Ventures and Advanced Technology Ventures. The company previously raised $72.2 million.